These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38484307)

  • 1. The Role of [
    Civan C; Ozkan ZG; Ozkan B; Isik EG; Erdogdu E; Has Simsek D; Duman S; Sanli Y; Kara M; Kuyumcu S; Toker A
    Cancer Biother Radiopharm; 2024 Jun; 39(5):373-380. PubMed ID: 38484307
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and prognostic values of 2-[
    Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
    Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
    Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of
    Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
    Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral metabolic heterogeneity by
    Chao F; Wang R; Han X; Huang W; Wang R; Yu Y; Lin X; Yuan P; Yang M; Gao J
    Thorac Cancer; 2024 Jun; 15(18):1437-1445. PubMed ID: 38757212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.
    Treglia G; Sadeghi R; Giovanella L; Cafarotti S; Filosso P; Lococo F
    Lung Cancer; 2014 Oct; 86(1):5-13. PubMed ID: 25175317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiating the grades of thymic epithelial tumor malignancy using textural features of intratumoral heterogeneity via (18)F-FDG PET/CT.
    Lee HS; Oh JS; Park YS; Jang SJ; Choi IS; Ryu JS
    Ann Nucl Med; 2016 May; 30(4):309-19. PubMed ID: 26868139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immunity is related to
    Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
    Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.
    Benveniste MF; Moran CA; Mawlawi O; Fox PS; Swisher SG; Munden RF; Marom EM
    J Thorac Oncol; 2013 Apr; 8(4):502-10. PubMed ID: 23446204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
    Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
    Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.
    Lococo F; Cesario A; Okami J; Cardillo G; Cavuto S; Tokunaga T; Apolone G; Margaritora S; Granone P
    Lung Cancer; 2013 Nov; 82(2):245-51. PubMed ID: 23992878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of metabolic response with
    Segreto S; Fonti R; Ottaviano M; Pellegrino S; Pace L; Damiano V; Palmieri G; Del Vecchio S
    Cancer Imaging; 2017 Mar; 17(1):10. PubMed ID: 28264726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network.
    Han S; Oh JS; Kim YI; Seo SY; Lee GD; Park MJ; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Clin Nucl Med; 2022 Jul; 47(7):590-598. PubMed ID: 35675135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.
    Seki N; Sakamoto S; Karube Y; Oyaizu T; Ishihama H; Chida M
    Ann Nucl Med; 2014 Apr; 28(3):257-62. PubMed ID: 24430867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG-PET/CT predicts grade of malignancy and invasive potential of thymic epithelial tumors.
    Ito T; Suzuki H; Sakairi Y; Wada H; Nakajima T; Yoshino I
    Gen Thorac Cardiovasc Surg; 2021 Feb; 69(2):274-281. PubMed ID: 32734427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of 18F-FDG PET/computed tomography in predicting the simplified WHO grade of malignancy in thymic epithelial tumors.
    Zhao J; Wang H; Li Q
    Nucl Med Commun; 2020 Apr; 41(4):405-410. PubMed ID: 32032191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superiority of [
    Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
    Viti A; Terzi A; Bianchi A; Bertolaccini L
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparameter diagnostic model based on
    Wang G; Du L; Lu X; Liu J; Zhang M; Pan Y; Meng X; Xu X; Guan Z; Yang J
    BMC Cancer; 2022 Aug; 22(1):895. PubMed ID: 35974323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.